ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Geeky News Reports on ObvioHealth's Collaboration with Chemist Warehouse to Revolutionise Clinical Trials in Australia

By: IssueWire

Surrey, United Kingdom Dec 5, 2023 (Issuewire.com) - Geeky News is pleased to announce the publication of a new article. It details a strategic partnership between ObvioHealth, a prominent Virtual Research Organisation (VRO), and Chemist Warehouse, Australia's largest retail pharmacy chain. 

The article sheds light on the collaboration aimed at transforming Australia's clinical trial landscape. The two companies hope to accomplish this by making health research more convenient and accessible.

This landmark alliance is set to boost patient recruitment significantly and expand the reach of clinical trials across Australia. Chemist Warehouse plans to utilise a multi-channel communication strategy, harnessing its extensive media assets such as wellness magazines, television programmes, and newspaper supplements to inform and engage potential trial participants.

"Not only is this a win for trial sponsors, but also for the participants--our customers--who will have access to trials they never knew existed," stated Jack Gance, Co-founder and Chairman of Chemist Warehouse. "Our stores are part of everyday life in Australian neighbourhoods, and our pharmacists are trusted members of those communities. As a dependable health and wellness source, we are eager to educate our customers about new opportunities that might be relevant to their health."

The partnership will leverage Chemist Warehouse's high-calibre telehealth service, Instant Consult, to facilitate patient evaluations. This integration of telehealth into the clinical trial model promises to enhance participant experiences. It will achieve this by facilitating contributions to home-based study. That, in turn, will help in reducing in-person clinic visits and fostering a more inclusive environment catering to diverse populations.

Recent data indicates a surge in clinical trial activities in Australia. The reason for this is the country's excellent response to COVID-19 and its appealing regulations and tax benefits for investments in life sciences. However, the challenge of recruiting still persists. 

"Two of the biggest recruitment hurdles are awareness and convenience, and this partnership tackles both," remarked Ivan Jarry, CEO of ObvioHealth. "The ability to communicate trial opportunities to an audience in a place where they are likely to be receptive, coupled with telehealth services to reduce participant burden, makes sense all around."

11% of clinical trial sites have historically been unable to recruit a single patient and 37% facing under-recruitment. The strategic collaboration between ObvioHealth and Chemist Warehouse is a significant step towards overcoming these barriers. It will also expedite the development of effective therapeutics.

For more insights into this transformative partnership, read the full article on Geeky News: https://www.geekynews.co.uk/obviohealth-partners-with-chemist-warehouse/

Media Contact

Geeky News


press@geekynews.co.uk

+44 20 3800 1212

Parallel House, 32 London Road Guildford, Surrey

https://www.geekynews.co.uk/

Source :Geeky News

This article was originally published by IssueWire. Read the original article here.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.